ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      104,966.23
      0.52%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Biora Therapeutics Inc (BIOR) Quote

      Biora Therapeutics Inc

      Biora Therapeutics Inc (BIOR)

      Biora Therapeutics Inc (PK)
      0.5597
      0.00
      (0.00%)
      Closed January 19 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.5597
      Bid
      0.53
      Ask
      0.55
      Volume
      -
      0.00 Day's Range 0.00
      0.5269 52 Week Range 19.90
      Market Cap
      2.531M
      Previous Close
      0.5597
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      106,058
      Shares Outstanding
      4,522,702
      Dividend Yield
      -
      PE Ratio
      -0.03
      Earnings Per Share (EPS)
      -27.44
      Revenue
      4k
      Net Profit
      -124.12M

      About Biora Therapeutics Inc

      Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bioratherapeutics.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $0.56. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 0.5269 to $ 19.90.

      Biora Therapeutics currently has 4,522,702 shares outstanding. The market capitalization of Biora Therapeutics is $2.53 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.03.

      Ask ADVFN Intelligence (AI)

      BIOR Latest News

      More News

      Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

      Sale process will help enable next stage of product development Secures up to $10.25 million in new financing to support ongoing business operations SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE...

      December 30 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      December 10 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 15 2024
      Edgar (US Regulatory)

      Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

      Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain...

      November 14 2024
      GlobeNewswire Inc.

      Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

      SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and...

      November 07 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 29 2024
      Edgar (US Regulatory)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.55970.55970.559700CS
      4000.55970.55970.559700CS
      12-3.0103-84.32212885153.574.420.52691060581.73021632CS
      26-6.8903-92.48724832217.457.90.52691621264.81753392CS
      52-11.7403-95.449593495912.319.90.52692573547.59890101CS
      156-214.4403-99.7396744186215287.50.526982350596.83246552CS
      260-214.4403-99.7396744186215287.50.526982350596.83246552CS

      BIOR - Frequently Asked Questions (FAQ)

      What is the current Biora Therapeutics share price?
      The current share price of Biora Therapeutics is $ 0.5597
      How many Biora Therapeutics shares are in issue?
      Biora Therapeutics has 4,522,702 shares in issue
      What is the market cap of Biora Therapeutics?
      The market capitalisation of Biora Therapeutics is USD 2.53M
      What is the 1 year trading range for Biora Therapeutics share price?
      Biora Therapeutics has traded in the range of $ 0.5269 to $ 19.90 during the past year
      What is the PE ratio of Biora Therapeutics?
      The price to earnings ratio of Biora Therapeutics is -0.03
      What is the cash to sales ratio of Biora Therapeutics?
      The cash to sales ratio of Biora Therapeutics is 977.78
      What is the reporting currency for Biora Therapeutics?
      Biora Therapeutics reports financial results in USD
      What is the latest annual turnover for Biora Therapeutics?
      The latest annual turnover of Biora Therapeutics is USD 4k
      What is the latest annual profit for Biora Therapeutics?
      The latest annual profit of Biora Therapeutics is USD -124.12M
      What is the registered address of Biora Therapeutics?
      The registered address for Biora Therapeutics is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
      What is the Biora Therapeutics website address?
      The website address for Biora Therapeutics is www.bioratherapeutics.com
      Which industry sector does Biora Therapeutics operate in?
      Biora Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BTCTBTC Digital Ltd
      $ 8.2697
      (73.73%)
      		61.45M
      BDMDBaird Medical Investment Holdings Ltd
      $ 8.80
      (62.36%)
      		18.63M
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      NUKKNukkleus Inc
      $ 29.97
      (45.98%)
      		19.09M
      GSITGSI Technology
      $ 3.97
      (44.36%)
      		87.7M
      DOGZDogness International Corporation
      $ 18.23
      (-58.77%)
      		740.45k
      ORKTOrangeKloud Technology Inc
      $ 3.02
      (-24.88%)
      		21.08M
      PMAXPowell Max Ltd
      $ 0.6364
      (-23.31%)
      		4.17M
      LGCBLinkage Global Inc
      $ 0.2876
      (-22.27%)
      		890.66k
      YYAIConnexa Sports Technologies Inc
      $ 0.8299
      (-20.20%)
      		602.48k
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      GCTKGlucoTrack Inc
      $ 0.0852
      (15.45%)
      		465.22M
      RIMEAlgorhythm Holdings Inc
      $ 0.0406
      (-4.02%)
      		387.23M
      TGLTreasure Global Inc
      $ 0.2459
      (14.75%)
      		267.1M
      NVDANVIDIA Corporation
      $ 137.71
      (3.10%)
      		201.4M

      Discussion

      View Full Feed
      TenKay TenKay 4 minutes ago
      MULN is now a delinquent SEC filer.
      MULN
      bigtalan bigtalan 4 minutes ago
      No problem , i was just asking was that from 2019
      RSPI
      JamesF1 JamesF1 4 minutes ago
      Shortage is definitely ongoing here in the USA. Adderall and Adderall XR generics are still frequently out of stock from all manufacturers (including Elite) at Cardinal. Vyvanse generics also. So far, I have not seen Elite’s Vyvanse listed at Cardinal. I think Cencora (AmeriSource) is Elite’s bi
      ELTP
      Participation_trophy_inc Participation_trophy_inc 5 minutes ago
      FYI Monday is MLK day and the banks are closed . I know this doesn't effect Dubai and Europe where the ultra high net worth investment groups are located but the US banks won't reflect the $12.5 billion dollars on Monday. I know everyone is frustrated but waiting for the/wed for the $12.5 billion d
      PHIL
      thisismynuttoo thisismynuttoo 6 minutes ago
      Definitely a possibility.
      GMER
      ap17 ap17 6 minutes ago
      No worries here whatsoever, it brings attention to crypto by lots of new players, he mentioned his coin weeks ago, no surprise, now it has to compete with the big coins, it will come down and xrp and others will continue it's rise.....bank on it.🏦🏦🏦🤑🤑🤑
      XRPUSD
      thisismynuttoo thisismynuttoo 7 minutes ago
      One stated a long time ago. That the “lights will be out”. Is that statement one of those so called “real facts “? One has lost all credibility here. In my book.
      GMER
      capgain capgain 7 minutes ago
      I added a Philly - 6.5 straight to my Philly and under teaser.

      I'm done with that game, I think lol
      Slojab Slojab 7 minutes ago
      I've been coming down South for a few years and never saw it. Isn't it odd what companies will do to solve a "problem"? How hard is it to break spaghetti in half?

      That's what I do, btw. But then, I'm a guy and guys like to break things.`
      KVM KVM 7 minutes ago
      Where else do u find a company.

      That's profitable with low PE and S/P ratios.
      Has abundant cash and little debt.
      Has known short term and midterm developments and news.
      Has massive 2 bil pipeline and in multiple intl markets.
      In hot and growing industries a
      GRRR
      dia76ca dia76ca 8 minutes ago
      BP = Big Pharma
      CADL
      xxxx xxxx 8 minutes ago
      A sneeker

      Been a buyer for years 8,7,6 zeros

      Makes me smile :)
      ELONUSD
      Seminole Red Seminole Red 8 minutes ago
      Exclusive — Sen. Ron Johnson: ‘Most, if Not All’ of Trump’s Nominees Will Get at Least 50 Votes

      https://www.breitbart.com/politics/2025/01/18/exclusive-sen-ron-johnson-most-if-not-all-of-trumps-nominees-will-get-at-least-50-votes/?utm_medium=social&utm_source=facebook&fbclid=IwY2xjawH
      ddls ddls 8 minutes ago
      My security software says unsafe access.🤠

      Oh and one more thing, can you tell us when junk BIEL will leave this delusional launch pad?

      I mean come on we've been waiting 15 years...😎
      BIEL
      Hosai Hosai 10 minutes ago
      "as Blarca clearly beat ADNI for RETT in the excellence trial."

      Obv I didn't mean this literally as ADNI wouldn't apply in RETT however if there was an equivalent it would have beaten that expected RETT deterioration, it beat DAYBUE as a cross comparison on absolute meaures.
      AVXL
      frrol frrol 10 minutes ago
      You get a thanks anyway. I looked for that slide a couple weeks ago too.
      AVXL
      ironhammer ironhammer 10 minutes ago
      nice find on NBRI thanks for sharing the DD this is going to be a great 2025
      NBRI
      Signor Signor 11 minutes ago
      style="caret-color: rgb(28, 28, 28); color: rgba(28, 28, 28, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px; letter-spacing: 0.1px; background-color: rgba(251, 250, 246, 1)"Exceptions to the general rule do exist where liability  carry over with asset purchase. One exception is where t
      FOXO RNVA
      Signor Signor 12 minutes ago
      color="#1c1c1c" style="caret-color: rgb(28, 28, 28); letter-spacing: 0.1px; background-color: rgba(251, 250, 246, 1)"Exceptions to the general rule do exist where liability  carry over with asset purchase. One exception is where the successor is a mere continuation of the predecessor(). How do we kn
      FOXO RNVA
      SSKILLZ1 SSKILLZ1 12 minutes ago
      Pick 4 Contest #21 Standings (Week 2)

      Congrats to our current leader KNOWLEDGEISKING up 24.53% so far in the contest. There are 15/39 portfolio up in the contest or 38.46%. So without any further ado the info. is below.
      [pre]
      Alias % Gain/Loss
      McMagyar McMagyar 13 minutes ago
      Just add another 0 to the right 
      This Corp sham public ownership should not be allowed to be traded. There is only one share that votes..the rest is.. well what do you own when you have no say in what you own?
      Nothing
      PPCB
      $27 $27 13 minutes ago
      You meant preferreds I assume not warrants...anyways all back dividends on all class of preferreds will be paid...illegal government taking.
      FNMA
      meixatech meixatech 14 minutes ago
      The point is that Lippa likely was a substantial beneficiary of that sale.
      RSPI
      SSKILLZ1 SSKILLZ1 16 minutes ago
      The Picks For Pick 4 Contest #21 (Revised)

      Commentary: This basically shows what everyone has now in the contest. The bolded Picks are things that were changed since the start of the contest.

      [pre]
      Alias SP #1 SP #2
      AES AMRN APLD
      Konaploinks Konaploinks 17 minutes ago
      It’s early here. Anyway. You get the idea. Read my first post early this morning to last post at the top, last. Zzzzzzzzzz. Keep your eye on IonQ
      IONQ

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads